Computational/in silico methods in drug target and lead prediction

Abstract Drug-like compounds are most of the time denied approval and use owing to the unexpected clinical side effects and cross-reactivity observed during clinical trials. These unexpected outcomes resulting in significant increase in attrition rate centralizes on the selected drug targets. These...

Ausführliche Beschreibung